Enhancement of therapeutic response to standard-of-care drugs employed against hepatocellular carcinoma by hitting metabolic dependencies

Responsabile scientifico: prof. Piscaglia Fabio

Ambiti: Medicina interna e medicine specialistiche

Ente finanziatore: MUR

Durata: 18/10/2023 - 17/10/2025